naltrexone and androstenedione

naltrexone has been researched along with androstenedione in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Bauman, M; Bullen, BA; Evans, WJ; Henley, K; McArthur, JW; Pehrson, J; Skrinar, GS; Turnbull, BA; Turner, A	1
Andrić, S; Kostić, T; Kovacević, R; Marić, D	1

Trials

1 trial(s) available for naltrexone and androstenedione

Article	Year
Nalmefene enhances LH secretion in a proportion of oligo-amenorrheic athletes. Acta endocrinologica, 1993, Volume: 128, Issue:4 Topics: Adult; Amenorrhea; Analysis of Variance; Androstenedione; Dehydroepiandrosterone; Estradiol; Female; Humans; Luteinizing Hormone; Menstruation; Naltrexone; Narcotic Antagonists; Oligomenorrhea; Physical Education and Training; Pituitary Gland; Progesterone; Sports; Substance Withdrawal Syndrome; Thyrotropin; Thyroxine; Time Factors; Vagina	1993

Article

Year

Nalmefene enhances LH secretion in a proportion of oligo-amenorrheic athletes.

Acta endocrinologica, 1993, Volume: 128, Issue:4

Topics: Adult; Amenorrhea; Analysis of Variance; Androstenedione; Dehydroepiandrosterone; Estradiol; Female; Humans; Luteinizing Hormone; Menstruation; Naltrexone; Narcotic Antagonists; Oligomenorrhea; Physical Education and Training; Pituitary Gland; Progesterone; Sports; Substance Withdrawal Syndrome; Thyrotropin; Thyroxine; Time Factors; Vagina

1993

Other Studies

2 other study(ies) available for naltrexone and androstenedione

Article	Year
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
The effect of acute stress and opioid antagonist on the activity of NADPH-P450 reductase in rat Leydig cells. The Journal of steroid biochemistry and molecular biology, 1998, Volume: 66, Issue:1-2 Topics: 17-alpha-Hydroxyprogesterone; Androstenedione; Animals; Cytochrome Reductases; Cytochrome-B(5) Reductase; Leydig Cells; Male; NADH, NADPH Oxidoreductases; NADPH-Ferrihemoprotein Reductase; Naltrexone; Narcotic Antagonists; Progesterone; Quaternary Ammonium Compounds; Rats; Rats, Wistar; Steroid 17-alpha-Hydroxylase; Steroids; Stress, Physiological; Testis; Testosterone	1998

Article

Year

Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.

Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008

The effect of acute stress and opioid antagonist on the activity of NADPH-P450 reductase in rat Leydig cells.

The Journal of steroid biochemistry and molecular biology, 1998, Volume: 66, Issue:1-2

Topics: 17-alpha-Hydroxyprogesterone; Androstenedione; Animals; Cytochrome Reductases; Cytochrome-B(5) Reductase; Leydig Cells; Male; NADH, NADPH Oxidoreductases; NADPH-Ferrihemoprotein Reductase; Naltrexone; Narcotic Antagonists; Progesterone; Quaternary Ammonium Compounds; Rats; Rats, Wistar; Steroid 17-alpha-Hydroxylase; Steroids; Stress, Physiological; Testis; Testosterone

1998